COVID 19-Caregivers IGg Seroconversion

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

130 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-25

Study Completion Date

2020-12-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

According to recent publications, the percentage of caregivers infected with COVID 19 is evaluated between 10 and 30% . This great variability is due, on the one hand to the intensity of the influx of covid plus patients and, on the other hand, to the disparity in the preparation of caregivers in the face of this emergency. Indeed, we can understand that the strict application of hygiene rules can be faulted in the face of the volume of patients, the lack of protective equipment and the lack of specific training for caregivers in this area. As a result, within healthcare teams, there are many questions that generate anxiety: will I be able to provide care properly while protecting myself from the risk of contamination? This anxiety is also present and sometimes manifests itself aggressively in the entourage or in the vicinity of caregivers, due to lack of scientific data adapted to the local ecology of the crisis.

Thus, the aim of this study is to show that the risk for caregivers of being contaminated by COVID in an area dedicated to COVID positive patients is no higher than being a caregiver in a non-COVID area that he either in the adult or pediatric sector.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Serological Study of the Exposure of Personnel to COVID-19

NCT04422977

Sars-CoV2

COMPLETED NA

Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff

NCT04896788

Hospital Staff Vaccined Againt COVID-19

UNKNOWN NA

Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution

NCT04664023

Covid19

COMPLETED

COVID-19 Seroprevalence in Pregnant Women and Blood Donors

NCT04893057

COVID-19 Respiratory Infection

COMPLETED

Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.

NCT04322279

Coronavirus

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection, COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Covid area

Blood sampling

Intervention Type OTHER

3 blood samples (D0, D15 and D30) will be taken from each participant

Non-Covid area

Blood sampling

Intervention Type OTHER

3 blood samples (D0, D15 and D30) will be taken from each participant

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood sampling

3 blood samples (D0, D15 and D30) will be taken from each participant

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* caregivers staff assigned to a non-intensive care COVID service
* or caregivers staff assigned to a non-COVID adult service
* or caregivers staff assigned to a non-COVID pediatric service
* Age \> = 18 years old
* With health insurance
* Express consent